BioWorld

Aug. 26, 2003

Coley Raises $35M To Finance Pipeline In Cancer, Viral Disease

Coley Pharmaceutical Group Inc. secured $35 million in private financing to fund further development of its clinical pipeline. (BioWorld Today) Read More

Amgen Gains Broadened Label For Enbrel In Psoriatic Arthritis

Roswell Scientists Seek To Crack Incurable Deadly Syndrome By Plumbing Albino Mice Mutations

NewNeural Using Marrow Stem Cells For CNS Diseases, Injury

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Dec. 17, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for December 17, 2024.

Second insulin receptor offers new therapeutic avenues

BioWorld Science

Investigators at the Helmholtz Institute have shown that inceptor, an inhibitor of the insulin signaling pathway, acted by binding insulin and targeting it for...

Drug duo to Repare lack in gyno cancers? Phase I shows promise

BioWorld

Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

Mechanism underlying so-called idiopathic autism inception unveiled

BioWorld Science

Investigators at the Institute for Research in Biomedicine (IRB Barcelona) have unraveled how and why the absence of a neuronal microexon in cytoplasmic...